Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
The provision of a vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 3 500 000 doses of vaccine.
Additional information: This future opportunity was originally published 5 February 2016 under the Commercial Medicines Unit as the contact organisation. The original notice has now been withdrawn and this new notice reflects the contact address as Department of Health.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Pfizer Ltd | 00526209 | ~£0 estimated from lot values | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Hanover Communications International Limited (3 quarters) Ovid Consulting Ltd (3 quarters) Incisive Health Ltd (1 quarter) MHP Communications (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
Government spending data: This supplier has received £205,888,548 in 73 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Ministry of Defence (2019-01-21 to 2026-03-12). View full payment history →